On Invalid Date, Bionano Genomics (NASDAQ: BNGO) reported Q2 2023 earnings per share (EPS) of -$1.24, up 9.73% year over year. Total Bionano Genomics earnings for the quarter were -$38.91 million. In the same quarter last year, Bionano Genomics's earnings per share (EPS) was -$1.13.
As of Q3 2023, Bionano Genomics's earnings has grown year over year. Bionano Genomics's earnings in the past year totalled -$146.52 million.
What is BNGO's earnings date?
Bionano Genomics's earnings date is Invalid Date. Add BNGO to your watchlist to be reminded of BNGO's next earnings announcement.
What was BNGO's revenue last quarter?
On Invalid Date, Bionano Genomics (NASDAQ: BNGO) reported Q2 2023 revenue of $8.66 million up 29.87% year over year. In the same quarter last year, Bionano Genomics's revenue was $6.67 million.
What was BNGO's revenue growth in the past year?
As of Q3 2023, Bionano Genomics's revenue has grown 35.12% year over year. This is 29.5 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 5.62%. Bionano Genomics's revenue in the past year totalled $31.51 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.